-
00:00
1.
Nocturia and Nocturnal Enuresis
-
00:43
2.
Slide 2
-
01:08
3.
Nocturia
-
02:38
4.
NOCTURNAL POLYURIA
-
03:07
5.
Circadian Urine Production
-
03:31
6.
Circadian ADH Production
-
03:46
7.
NOCTURIA TREATMENT OFTEN FAILS DUE TO QUESTIONABLE DIAGNOSTIC ASSUMPTIONS
-
04:43
8.
Poor results are observed with OAB/BPO therapy for nocturia treatment
-
05:38
9.
TURP FAILS TO IMPROVE NOCTURIA IN MEN
-
06:39
10.
UNDERLYING NOCTURAL POLYURIA (NP) IS THE REASON WHY α1-BLOCKER TREATMENT OFTEN FAILS TO TREAT NOCTURIA
-
07:10
11.
EVALUATION
-
08:34
12.
VALUE OF FVCS FOR APPROPRIATEDIAGNOSIS AND TREATMENT
-
09:16
13.
VOIDING DIARY ANALYSIS: CASE STUDIES
-
12:07
14.
Simple Algorithm for Classification and Treatment of Nocturia
-
13:53
15.
ManagementLifestyle modification
-
15:06
16.
ManagementLifestyle modification
-
15:52
17.
ManagementLifestyle modification
-
16:23
18.
WHAT IS DESMOPRESSIN?
-
17:12
19.
Desmopressin has Level 1b-Evidence andGrade A-Recommendation
-
17:39
20.
COMBINATION THERAPY
-
18:07
21.
Possible therapy combinations
-
18:17
22.
Poor results are observed with OAB/BPO therapy for nocturia treatment
-
18:22
23.
DESMOPRESSIN + α1 ANTAGONISTS DECREASE NOCTURIA AND IMPROVE IPSS SCORES IN PATIENTS WITH LUTS
-
18:34
24.
DESMOPRESSIN + LUTS AGENTS ARE AN EFFECTIVE TREATMENT FOR NOCTURIA IN PATIENTS WITH BPH
-
18:56
25.
DESMOPRESSIN + LUTS AGENTS ARE A WELL TOLERATED TREATMENT FOR NOCTURIA IN PATIENTS WITH BPH
-
19:41
26.
Practical Considerations for Desmopressin Use
-
20:47
27.
SUMMARY: CURRENT DIAGNOSIS AND TREATMENT RECOMMENDATIONS
-
21:23
28.
Nocturnal Enuresis
-
21:43
29.
Nocturnal Enuresis
-
22:13
30.
Quantification of Nocturnal Enuresis
-
22:42
31.
Subtypes of Nocturnal Enuresis
-
23:12
32.
Epidemiology of Nocturnal Enuresis
-
23:41
33.
Balance between Bladder capacity and Nocturnal urine vol
-
23:45
34.
-
23:54
35.
Treatment of Nocturnal Enuresis
-
24:30
36.
DDAVP Therapy in Nocturnal Enuresis in Children
-
24:56
37.
Thanks for your attention